Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.79B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$576M |
| 3 |
Microsoft
MSFT
|
+$546M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$436M |
| 5 |
JPMorgan Chase
JPM
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.48B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$765M |
| 4 |
Apple
AAPL
|
+$656M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$526M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.23% |
| 2 | Technology | 2.7% |
| 3 | Consumer Discretionary | 1.66% |
| 4 | Financials | 1.18% |
| 5 | Communication Services | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBIO
11126
DELISTED
Generation Bio
GBIO
| $70.5K | ﹤0.01% |
1,281
-1,406
| -52% | -$64.5K |
|
11127
Epsilon Energy
EPSN
$179M
| $70.2K | ﹤0.01% |
13,138
-72,384
| -85% | -$374K |
|
11128
CALL
Pyxis Oncology
PYXS
$277M
| $70.1K | ﹤0.01% |
+27,400
| New | +$86.9K |
|
|
CURO
11129
DELISTED
CURO Group Holdings Corp.
CURO
| $70.1K | ﹤0.01% |
51,894
+27,139
| +110% | +$41.6K |
|
|
PTRS
11130
DELISTED
Partners Bancorp Common Stock
PTRS
| $69.8K | ﹤0.01% |
11,279
-13,515
| -55% | -$87.9K |
|
|
CCLP
11131
DELISTED
CSI Compressco LP
CCLP
| $69.8K | ﹤0.01% |
+57,220
| New | +$66.9K |
|
|
VIVS
11132
VivoSim Labs
VIVS
$3.92M
| $69.8K | ﹤0.01% |
3,442
-1,664
| -33% | -$37.5K |
|
11133
CALL
AC Immune
ACIU
$269M
| $69.6K | ﹤0.01% |
+23,500
| New | +$51.3K |
|
11134
PUT
AudioEye
AEYE
$90.4M
| $69.4K | ﹤0.01% |
14,200
-13,000
| -48% | -$79.5K |
|
11135
Lifetime Brands
LCUT
$212M
| $69.3K | ﹤0.01% |
+12,266
| New | +$62.6K |
|
|
TIGR
11136
PUT
UP Fintech Holding
TIGR
$910M
| $69.3K | ﹤0.01% |
24,400
-48,900
| -67% | -$145K |
|
11137
electroCore
ECOR
$87.5M
| $69.2K | ﹤0.01% |
+14,129
| New | +$77.2K |
|
11138
Eledon Pharmaceuticals
ELDN
$270M
| $69.2K | ﹤0.01% |
+50,502
| New | +$105K |
|
11139
CALL
SELLAS Life Sciences
SLS
$3.07B
| $68.9K | ﹤0.01% |
43,900
-112,000
| -72% | -$180K |
|
|
BWAY
11140
Brainsway
BWAY
$579M
| $68.8K | ﹤0.01% |
+60,606
| New | +$54.3K |
|
11141
Paysign
PAYS
$743M
| $68.6K | ﹤0.01% |
27,995
-105,551
| -79% | -$325K |
|
11142
PUT
StealthGas
GASS
$353M
| $68.6K | ﹤0.01% |
+16,100
| New | +$48.8K |
|
11143
PUT
Applied Optoelectronics
AAOI
$9.62B
| $68.5K | ﹤0.01% |
11,500
-2,000
| -15% | -$5.25K |
|
|
CKPT
11144
CALL
DELISTED
Checkpoint Therapeutics
CKPT
| $68.4K | ﹤0.01% |
27,700
-27,000
| -49% | -$73.8K |
|
|
OSG
11145
CALL
DELISTED
Overseas Shipholding Group Inc.
OSG
| $68.4K | ﹤0.01% |
16,400
-10,800
| -40% | -$41.7K |
|
|
CAN
11146
CALL
Canaan Creative
CAN
$330M
| $68.4K | ﹤0.01% |
32,100
-37,100
| -54% | -$89.9K |
|
11147
Savara
SVRA
$1.13B
| $68.2K | ﹤0.01% |
21,339
-678,820
| -97% | -$1.6M |
|
|
BRFS
11148
PUT
DELISTED
BRF SA
BRFS
| $68K | ﹤0.01% |
+35,800
| New | +$55.2K |
|
11149
The Beachbody Company
BODI
$43.6M
| $67.8K | ﹤0.01% |
3,239
+1,762
| +119% | +$40.6K |
|
|
THRN
11150
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $67.6K | ﹤0.01% |
14,383
-3,361
| -19% | -$15.4K |
|
Similar funds
Jeff Yass's Q2 2023 Portfolio in Review
As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2023 filing shows 1,371 new, 4,862 increased, 5,559 reduced and 1,866 closed positions. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M. The largest sale was Invesco QQQ Trust, an estimated $2.48B.
By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
- Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
- Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
- Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
- Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
- Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
- Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.
Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.